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Abstract Previous experimental studies suggested that
mesenchymal stem cell transplantation causes cardiac nerve
sprouting; however, whether bone marrow (BM)-derived
mononuclear cells (MNC) and endothelial progenitor cells
(EPC) can also lead to cardiac nerve sprouting and alter gap
junction expression remains unclear. We investigated the
effect of electroanatomical mapping-guided direct intramyo-
cardial transplantation of BM-MNC (n08) and CD31+EPC
(n08) compared with saline control (n08) on cardiac nerve
sprouting and gap junction expression in a swine model of
chronic ischemic myocardium. At 12 weeks after transplan-
tation, the distribution and density of cardiac nerve sprout-
ing were determined by staining of tyrosine hydroxylase
(TH) and growth associated protein 43(GAP-43) and ex-
pression of connexin 43 in the targeted ischemic and remote
normal myocardium. After 12 weeks, no animal developed
sudden death after the transplantation. There were no sig-
nificant differences in the number of cells with positive
staining of TH and GAP-43 in the ischemic and normal
myocardium between three groups. Furthermore, expression
of connexin 43 was also similar in the ischemic and normal
myocardia in each group of animals (P>0.05). The results of
this study demonstrated that intramyocardial BM-derived
MNC or EPC transplantation in a large animal model of
chronic myocardial ischemia was not associated with increased
cardiac nerve sprouting over the ischemic myocardium.
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Introduction
Stem cell transplantation has been investigated as a
potential novel therapy for patients with ischemic heart
disease [1]. Currently, several cell types including bone
marrow (BM)-derived mononuclear cells (MNC), endo-
thelial progenitor cells (EPC), mesenchymal stem cell
(MSC) and skeletal myoblasts have been tested in large
animal models of chronic myocardial ischemia [2–4]
and in clinical studies for cardiac repair [5–7]. Apart
from clinical efficacy, a major issue with this promising
therapeutic approach is the potential proarrhythmic con-
sequences of cell therapy [8, 9].
Potential mechanisms of proarrhythmia after stem cell
therapy include the heterogeneity of action potential of
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transplanted cells, lack of cell-to-cell connection and cardiac
nerve sprouting. In experimental [10, 11] and clinical [12]
studies, cardiac nerve sprouting was associated with in-
creased incidence of ventricular tachyarrhythmia and sud-
den cardiac death. In large animal models of myocardial
infarction [13, 14], MSC transplantation increased the mag-
nitude of cardiac nerve sprouting. However, the effect of
BM-derived MNC or EPC, which are currently the most
common cell types tested in clinical trials on cardiac nerve
sprouting, remains unclear. The aim of this study was to
determine whether BM-MNC and BM-EPC transplantation
can stimulate cardiac nerve sprouting and alter gap junction
expression in chronic ischemic myocardium.
Methods
Porcine Model of Chronic Myocardial Ischemia
Adult minipigs (body weight of 45–50 kg) underwent ame-
roid constrictor (Research Instruments SW, USA) implanta-
tion around the proximal left circumflex (LCX) artery to
induce chronic myocardial ischemia as described previously
[4]. Animals were anesthetized with ketamine (15 mg/kg
intramuscularly) and maintained by inhalation of 1.5% iso-
flurane. An ameroid constrictor was placed around the prox-
imal portion of the LCX artery via a left thoracotomy to
gradually induce progressive total occlusion of the artery
over a 4-week period without causing acute myocardial
infarction. This animal experiment was approved by the
Committee on the Use of Live Animals in Teaching and
Research of the University of Hong Kong.
Study Protocol
This was a substudy of a previous animal study which
investigated the functional effect of intramyocardial injec-
tion of BM-derived stem cells for treatment of chronic
myocardial ischemia [4]. As described previously, at 8 weeks
after ameroid constrictor implantation, the pigs with total
occlusion of LCX artery and evidence of chronic myocar-
dial ischemia as detected by left ventricular (LV) electrome-
chanical mapping (NOGA, Biosense Webster) were selected
for study. A total of 24 pigs were randomized to receive
intramyocardial injection of BM-MNC (n08), BM CD31-
positive EPC (n08) or saline control (n08), respectively, as
guided by electromechanical mapping [4]. A total of 12–15
injections (0.1 ml per injection) were performed over the
areas with hibernating myocardium as documented by elec-
troanatomical mapping. Animals were sacrificed 12 weeks
after intramyocardial injection for histological and immuno-
histochemical assessments to examine the in vivo effect of
treatment on the ischemic myocardium. Furthermore, con-
trast LV angiogram was performed before and at 12 weeks
after intramyocardial injection to assess LVejection fraction.
Preparation of Autologous BM-derived Cells
At 8 weeks after placement of the ameroid constrictor,
animals were anesthetized with ketamine (15 mg/kg IM)
and 60 ml of BM blood aspirated from the right iliac crest.
BM-MNCs were isolated by Ficoll density gradient centri-
fugation [4, 5]. BM cells were washed twice in phosphate-
buffered saline, resuspended in phosphate-buffered saline
enriched with 10% autologous plasma to 1×107 MNCs per
milliliter and returned directly to the laboratory for use. Cell
sorting of BM-EPC was performed using MACS bead se-
lection method for CD31 (BD Pharmingen, USA) because
antiswine CD34 or CD133 antibody were not available [4].
BM-EPCs were resuspended in phosphate-buffered saline
enriched with 10% autologous plasma for injection. BM
suspensions were tested by flow cytometry (Elite, Beckman
Coulter, Fullerton, CA, USA) with directly conjugated anti-
bodies against CD31 (BD Pharmingen, USA). Cell viability
was >95% in all BM preparations.
Immunohistochemical Staining
Cardiac nerve sprouting was studied with immunocyto-
chemical techniques [15, 16]. Paraffin sections (4 μm) were
cut from ischemic LV wall (LCX region) and septum (nor-
mal myocardium), respectively, and were then deparaffi-
nized, rehydrated and incubated in 10% normal goat serum
(Vector Labs, Burlingane, CA). Accordingly, antibodies in-
cluding antigrowth-associated protein 43 (GAP-43) antibody
and antityrosine hydroxylase (TH) antibody (monoclonal
mouse anti-GAP-43 and anti-TH, Zymed Inc., USA. 1:250,
respectively) were used for immunocytochemical staining.
Furthermore, connexin 43 (monoclonal mouse anticonnexin
43 (Sigma-Aldrich, USA; 1:200) immunostaining for gap
junctions was also performed [14]. Heat-induced epitope re-
trieval methods were used in which horseradish peroxidase
was conjugated with the second antibody and then diamino-
benzidine (DAB) to produce a staining pattern. Further-
more, negative controls were performed in which primary
antibodies were omitted. In each animal, two random
samples were taken from the ischemic area and two
samples from the normal area. For each slide, five regions
were randomly selected and examined. As a result, the
nerve density and gap junction density were measured by
the number of both GAP-43 and TH-positive cells, and
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connexin 43 positive cells, respectively, in a total of 10
randomly selected fields not only from the ischemic area
but also from an area remote to ischemic myocardium at
400×magnification. The results were expressed as the
number of positive cells per square millimeter. All meas-
urements were counted in a blinded fashion.
Statistical Analysis
Data were expressed as mean±1 standard error of the mean
(SEM). Statistical comparisons were performed with Stu-
dent's t-test as appropriate. Comparisons between different
groups were performed using one-way ANOVA followed by
Bonferroni multiple comparison. Calculations were per-
formed using SPSS software (version 15.0). p<0.05 was
considered statistically significant.
Results
After intramyocardial injection, none of the animals with
chronic myocardial ischemia developed sudden death after
12 weeks of follow-up. As determined by LV angiogram,
there were no significant differences in LV ejection fraction
between the three groups (48±6%, versus 49±10% versus
47±8%, P>0.05) before intramyocardial injection. At
12 weeks, transplantation of BM-MNC significantly in-
creased LV ejection fraction as compared with before intra-
myocardial injection (54±6%, P00.045). However, there
were no significant improvements in LV ejection fraction
after BM-EPC (52±6%, P00.12) or saline (49±10%,
P00.8) injection as compared with before intramyocar-
dial injection (Fig. 1).
In the control group, there were no significant differences
in the number of cells with positive staining of TH (5.47±0.92
versus 4.63±1.08 per mm2, P00.32) and GAP-43 (7.40±2.14
versus 8.66±2.88 per mm2, P00.68) between ischemic and
normal regions, suggesting that chronic myocardial ischemia
did not significantly increase cardiac nerve spouting or local
sympathetic activity (Figs. 2a and 3a).
In the BM-MNC group, there was a significant increase
in the number of cells with positive staining of TH (6.61±2.20
versus 3.41±1.31 per mm2, P00.025) but not GAP-43
(6.13±1.62 versus 5.91±2.19 per mm2, P00.87) over the
ischemic region as compared with the normal region. In
contrast, there were no significant differences in the number
of cell with positive staining of TH (4.17±1.11 versus
5.22±0.10 per mm2, P00.54) and GAP-43 (6.46±1.84
versus 10.09±1.86 per mm2, P00.09) between ischemic
and normal regions in the BM-EPC group. These findings
suggest that BM-MNC transplantation, but not BM-EPC,
increased the local sympathetic activity without nerve
spouting over the ischemic myocardium.
As compared with the control group, there were no
significant differences in the numbers of cells with positive
staining of TH (Fig. 2b, all P>0.05) and GAP-43 (Fig. 3b,
all P>0.05) over the ischemic and normal regions at
12 weeks after BM-MNC and BM-EPC transplantation.
Similarly, there were also no differences in the number of
GAP-43 and TH-positive cells over the ischemic and normal
regions at 12 weeks between the BM-MNC group and the
BM-EPC group (Fig. 2b, all P>0.05).
In the control, BM-MNC and BM-EPC groups, there
were significant decreases in the expression of connexin
43 over the ischemic regions as compared with the normal
regions (Fig. 4). As compared with the control group, there
were no significant differences in the expression of con-
nexin 43 over the ischemic and normal regions at 12 weeks
after BM-MNC and BM-EPC transplantation (Fig. 4b, all
P>0.05). Similarly, there were also no differences in ex-
pression of connexin 43 over the ischemic and normal
regions at 12 weeks between the BM-MNC group and the
BM-EPC group (Fig. 4b, all P>0.05).
Discussion
Consistent with previous clinical [5–7] and experimental
studies [4], our results demonstrated that transplantation of
BM-MNC cells into chronic ischemic myocardium im-
proved LV function. In contrast to previous experimental
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Fig. 1 Left ventricular (LV) ejection fraction before and 12 weeks
after transplantation of bone marrow mononuclear cells (BM-MNC,
n08), bone marrow endothelial progenitor cells (EPC, n08) or saline
control (n08), respectively
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studies in animals with myocardial infarction [10, 11],
we did not observe any increase in cardiac nerve sprout-
ing in the chronic ischemic myocardium as compared to
nonischemic myocardium. GAP-43 is a protein associat-
ed with axonal growth cone and is upregulated during
nerve sprouting, and TH is the rate-limiting enzyme of
norepinephrine synthesis, which serves as not only a
marker for sympathetic nerve location but also an indi-
rect indicator of sympathetic activity [16]. The combina-
tion of GAP-43 and TH staining can, therefore, precisely
reflect the sprouting of sympathetic nerves [13, 14]. In
this study, neither BM-MNC nor BM-EPC transplanta-
tion into chronic ischemic myocardium was associated
with increased cardiac nerve sprouting as compared to
control. Although the expression of connexin 43 was
decreased in the chronic ischemic myocardium as com-
pared with nonischemia in all three groups, BM-MNC
and BM-EPC transplantation did not affect the connexin
43 expression in the chronic ischemic myocardium as
compared to controls.
In large animal models of myocardial infarction [13, 14],
MSC transplantation increased the magnitude of cardiac
MNC EPC Saline
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Fig. 2 a Immunohistochemical
staining (arrows) and b number
of cells staining positive for
tyrosine hydroxylase (TH) in
the ischemic left ventricular
wall (LCX region) and septum
(normal myocardium) after
transplantation of bone marrow
mononuclear cells (BM-MNC,
n08), bone marrow endothelial
progenitor cells (EPC, n08) or
saline control (n08),
respectively
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nerve sprouting. In this study, we did not observe any
increase in nerve spouting after BM-MNC or BM-EPC
transplantation. Although the mechanism remains unclear,
the discrepancy in the results may be related to the different
animal models including the species of the animals used
(dogs versus farm pigs or minipigs) and the method to
induce myocardial ischemia/infarction (rapid pacing versus
coronary microembolization and constriction) as well as the
potential difference in the propensity of stimulating nerve
growth with BM-MNC and BM-EPC cells as compared
with MSC. It is well known that neurons and glial cells
have successfully been differentiated from MSC but not
BM-MNC or BM-EPC [16]. It is possible that the paracrine
effects of BM-MNC lead to increased cardiac nerve sprout-
ing and, thus, contribute to the improvement in cardiac
contractile function after transplantation [4, 17].
Furthermore, we observed that gap junction expres-
sion was not reduced significantly as determined by the
density of connexin 43 staining over the chronic ische-
mic myocardium and that BM-MNC or BM-EPC trans-
plantation did not alter the gap junction expression. In
addition to the well known role of cell-to-cell coupling
between cardiomyocytes, gap junctions also play an
important role in cell-to-cell communication under vari-
ous insult conditions such as hypoxia and ischemia [18].
Downregulation of the gap junctions in the ischemic
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Fig. 3 a Immunohistochemical
staining (arrows) and b number
of cells staining positive for
growth-associated protein 43
(GAP-43) in the ischemic left
ventricular wall (LCX region)
and septum (normal myocardi-
um) after transplantation of
bone marrow mononuclear cells
(BM-MNC, n08), bone marrow
endothelial progenitor cells
(EPC, n08) or saline control
(n08), respectively
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myocardium is a potential protective mechanism to re-
duce progression of cell death during chronic ischemia
[19, 20].
This study has several limitations. First, the protein
levels of TH and GAP-43 were not measured in this
study. Second, detailed heart rate and rhythm monitoring
for the presence of spontaneous cardiac arrhythmias as
well as sympathetic activity were not performed after the
transplantation due to the lack of long-term telemetry
monitoring system available in our laboratory. Therefore,
the incidence of nonsustained ventricular arrhythmias and
sympathetic activity after cell transplantation remains
unclear. Third, invasive electrophysiology to assess in-
ducible arrhythmia was also not performed. Nevertheless,
we did not observe any sudden death after cell transplan-
tation in this study. Forth, the differences in the results of
this study as compared with other studies [13, 14] might
also be due to the differences in the method to determine
cardiac nerve spouting.
Conclusions
In conclusion, the results of this study demonstrate that
intramyocardial BM-derived MNC or EPC transplantation
in a large animal model of chronic myocardial ischemia was
not associated with increased cardiac nerve sprouting over
the ischemic myocardium.
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Fig. 4 a Immunohistochemical
staining (arrows) and b density
of connexin 43 staining in the
ischemic left ventricular wall
(LCX region) and septum
(normal myocardium) after
transplantation of bone marrow
mononuclear cells (BM-MNC,
n08), bone marrow endothelial
progenitor cells (EPC, n08) or
saline control (n08),
respectively
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